4:18 PM
 | 
Jun 13, 2018
 |  BC Extra  |  Politics & Policy

China’s NHC releases guidelines for updating Rare Disease List

China's National Health Commission released guidelines for adding or updating rare diseases on its national list to encourage development of rare disease policies and therapies in the country.

NHC's notice states that interested bodies can submit applications to add diseases to the list to the commission's Expert Committee for Diagnosis, Therapy, and Insurance of Rare Diseases. The guidelines provide eligibility criteria for the list and information that should be included in the application, such as existing therapies and insurance policies available for the disease in China and other countries or regions. NHC said the list should be updated at least every two years.

In May, five Chinese government agencies including NHC published a national list of 121 qualified rare diseases to support diagnosis and treatment of such conditions in a move that could spur R&D and regulatory submissions for rare disease therapies (see BioCentury Extra, May 25).

The non-profit R&D-based Pharmaceutical Association Committee (RDPAC) plans to hold a working group meeting in late June to discuss policies related to rare diseases. The organization, made up of 40 pharma company members, said it will identify action plans for next steps to support rare disease policymaking in the country.

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

Purchase this article for limited one-time distribution and website posting

$750 USD